IL-13Rα2 is overexpressed in melanoma (8, 15), renal cell carcinoma (RCC) (16), adrenocortical carcinoma (ACC) (17, 18), and a variety of brain tumors (19–21). This evidence concerns the gene IL13RA2 and melanoma.